Top experts at world-renowned Johns Hopkins Medicine did a systematic review of existing statin studies. Unlike the FDA, they found no connection between short-term statin
Pramlintide (known by the brand name Symlin®, an FDA-approved diabetic drug) reduces Alzheimer’s amyloid-beta peptides in the lab. Learn how it improves learning and memory.
VIDEO+ARTICLE A cutting-edge lab in Cambridge is using human brain cells made in the lab to test experimental Alzheimer’s drugs. See how the use of
If you live with Alzheimer’s, the need for more research funds may be obvious to you, but not so obvious to the government. The Alzheimer’s
VIDEO+ARTICLE Cognoptix announced strong results in a clinical trial of its SAPPHIRE II eye test. It successfully identified Alzheimer’s via the human eye’s beta-amyloid signature.
VIDEO Watch this proud stand from the Colorado Senate. See a truly moving tribute to people with Alzheimer’s, as well as caretakers and the many
VIDEO+ARTICLE Simple eye tests have the potential to transform the way Alzheimer’s is detected and managed. Find out how two quick, low-cost Alzheimer’s eye tests
VIDEO+ARTICLE See the most successful basketball coach in history discuss her life since leaving the court to battle dementia. Find out about her new position
VIDEO Music legend Glen Campbell hasn’t let his battle with Alzheimer’s keep him from his music. His wife, Kim, tells USA TODAY about his life
VIDEO + ARTICLE Doctors think many Alzheimer’s drug trials fail because it is too late to cure the disease by the time people notice it.
P-tau217 is a blood-based marker for Alzheimer’s. See how it offers a simpler, cheaper way to analyze Alzheimer’s.
You cannot control the wind, But you can adjust your sails.
Alzheimer’s rates are on the rise. How is today’s best treatment, Leqembi (generic lecanemab) doing in the fight against it?
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
